Lilly in Lehigh Valley, Pennsylvania

In January 2026, we announced plans to invest more than $3.5 billion in a new manufacturing facility in the Lehigh Valley, Pennsylvania. The site will serve as Lilly's newest injectable medicine and device manufacturing facility that will produce next-generation weight-loss therapies. Lilly will utilize advanced technologies, including AI, machine learning, integrated monitoring, and data analytics, to enable efficient operations and a reliable supply of medicine.